Ashland Global Hlds

Ashland, Inc. engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. It operates through the following segments: Life Sciences, Personal Care, Special Additives, and Intermediates. The company was founded in 1924 and is headquartered in Wilmington, DE.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Ashland Global Hlds reports solid Q1 performance amidst regional challenges

Ashland Global Hlds' Q1 earnings call highlighted a mix of strong performance, challenges in certain regions, and opportunities for growth through strategic initiatives. The company's focus on enhancing shareholder value, addressing market uncertainties, and driving innovation positions it for future success.

Ashland Global Hlds faces Q2 challenges, eyes pharma growth

Ashland Global Hlds faced challenges in Q2 2023 from global uncertainties and destocking, impacting margins and earnings, while showing strength in the pharma and Life Sciences segments.
The company's strategic focus on M&A in growth areas and ending destocking actions in key segments present opportunities for revenue growth and value creation.
Despite challenges, Ashland's performance reflects resilience and strategic decision-making, with a positive outlook for cash flow improvement and long-term growth.
Investors should monitor the company's progress in addressing challenges, leveraging strengths, and capitalizing on opportunities to drive sustainable financial performance.

Ashland Global Hlds faces destocking challenges but emphasizes resilience and growth

Ashland Global Hlds faced challenges from customer destocking, leading to a decline in sales and adjusted EBITDA, but demonstrated resilience and strength in managing mix improvements and margins.
The company remains focused on innovation, growth opportunities, and market confidence, with investments in core assets and new technologies continuing despite market challenges.
Opportunities lie in new product initiatives, global expansion, and capacity additions in key technologies, positioning Ashland Global Hlds for future growth and success.
Despite short-term challenges, Ashland Global Hlds maintains a strategic outlook, emphasizing long-term strategies, market confidence, and a commitment to driving growth through innovation.

Ashland Global Hlds faces challenges but targets growth opportunities

Ashland Global Hlds faced challenges in Q4 and anticipates uncertainties in 2024 but remains focused on long-term growth opportunities.
The company is optimizing its portfolio, targeting new growth drivers, and managing costs effectively to navigate current market conditions.
Despite near-term challenges, Ashland is resilient and committed to maximizing upside potential while minimizing downside risks.
Management's emphasis on proactive inventory control, cost management, and strategic priorities underscores their commitment to long-term success.

Ashland Global Hlds reports mixed Q1 results, focuses on long-term growth

Ashland Global Hlds reported mixed Q1 results with sales decline and EBITDA decrease, focusing on long-term growth strategies and shareholder value creation.
Challenges include lower demand in key units, compensation adjustments, market dynamics, and cost management considerations, while opportunities lie in M&A, innovation, and market expansion.
Stability in certain business segments and strategic initiatives to optimize operations provide a foundation for future growth and profitability amidst current challenges.
Overall, Ashland's performance reflects a balancing act between short-term setbacks and long-term strategic positioning for sustainable growth and market competitiveness.

Ashland Global Hlds beats Q2 expectations, eyes growth opportunities

Ashland Global Hlds demonstrated resilience in Q2 2024, exceeding EBITDA outlook and focusing on strategic growth.
Despite challenges in pricing and market dynamics, the company maintains a strong financial position and growth focus.
Opportunities lie in innovation, segment growth, and EBITDA normalization above 2021 levels.
The company's performance reflects a balance of challenges, strengths, and a proactive approach to future growth.

Ashland reports solid Q4 results, eyes global growth opportunities

Ashland Global Hlds (ASH) delivered a resilient performance in Q4 2024, with sales and adjusted EBITDA showing positive growth trends.
Strategic priorities for fiscal year 2025 aim to address challenges, capitalize on opportunities, and drive profitable growth for the company.
Despite near-term uncertainties, Ashland remains optimistic about its long-term prospects and ability to navigate evolving market conditions.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.

Ashland (ASH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Ashland (ASH) Upgraded to Strong Buy: What Does It Mean for the Stock?

Novozymes A/S

Investors interested in stocks from the Chemical - Specialty sector have probably already heard of Ashland (ASH) and Novozymes A/S (NVZMY). But which of these two stocks presents investors with the better value opportunity right now?

ASH or NVZMY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Chemical - Specialty sector might want to consider either Ashland (ASH) or Novozymes A/S (NVZMY). But which of these two stocks offers value investors a better bang for their buck right now?

ASH vs. NVZMY: Which Stock Is the Better Value Option?

WILMINGTON, Del., July 17, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its third-quarter earnings release at approximately 5 p.m. ET on Tuesday, August 6, 2024. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 10 a.m. ET on Wednesday, August 7. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com .

Ashland sets date for fiscal 2024 third-quarter earnings release and conference call webcast

WILMINGTON, Del., June 18, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) has strengthened its performance  towards environmental, social and governance (ESG) practices and a more just and equitable society through  a relationship with the Fair Wage Network (FWN) to understand living wages for the company's 3,800 global employees. Following a rigorous and thorough process where compensation data for all employees was reviewed on an anonymous basis and steps were taken to remediate any pay gaps, Ashland achieved certification as a Global Living Wage Employer .

Ashland achieves certification by Fair Wage Network

Ashland (ASH) reported earnings 30 days ago. What's next for the stock?

Ashland (ASH) Up 4% Since Last Earnings Report: Can It Continue?

ACNB

Cabot

Deere & Company

Evercore

FactSet Research Systems

Hamilton Beach Brands Hld

Hyster-Yale Materials Handling

National Bank Hlds

NACCO Industries

Sun Life Financial

Advanced Drainage Systems

Watts Water Technologies

Thirteen dividend increases are featured, with RLI Corp leading the charge with a 49-year streak and a potential to become a dividend king next year. The list is created by merging data from the "U.S. Dividend Champions" spreadsheet and upcoming dividend data from NASDAQ. The article provides additional metrics, tickers by yield and growth rates, and historical returns for investors to consider before making investment decisions.

13 Upcoming Dividend Increases

Boot Barn Hlds

Essential Properties Realty Trust Inc

Investors looking for breakout stocks to buy that Wall Street already loves should find it easier now that the S&P 500 is near 52-week and all-time highs. The index is up nearly 12% year to date thanks to an almost 5% gain in the past month.

3 Future Breakout Stocks That Wall Street Is Already Loving

Ashland (ASH) is set to sell its nutraceuticals business to Turnspire Capital Partners, with the deal expected to close in third-quarter 2024.

Ashland (ASH) to Divest Nutraceuticals Business to Turnspire

WILMINGTON, Del., May 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is announcing the appointment of Ashish K. Kulkarni to its Board of Directors. Kulkarni is the CEO of Kebotix, a startup company focused on commercializing artificial intelligence methods into new material commercialization. He is the former executive vice president and chief innovation officer, GAF, former chief technology and innovation officer, Avantor and former chief technology and innovation officer, Celanese Corporation. He will serve on the Board's Environmental, Health, Safety and Quality, and Compensation Committees, effective May 6, 2024.  Prior to Celanese, Kulkarni held leadership positions at United Technologies Corporation, American Standard and General Electric.

Ashland Board appoints Ashish K. Kulkarni as new director

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Ashland (ASH) is a Top-Ranked Momentum Stock: Should You Buy?

NEW YORK--(BUSINESS WIRE)--Turnspire Capital Partners LLC (“Turnspire”) announced today that an affiliate has signed a definitive agreement to acquire the nutraceuticals business of Ashland Inc. (NYSE: ASH) (“Ashland Nutraceuticals” or the “Business”). Ashland Nutraceuticals is a leading provider of proprietary nutrition ingredients and custom formulation services that supplies a broad portfolio of both active ingredients and formulation aids to nutritional product companies. The Business also.

Turnspire Capital Partners to Acquire Ashland Nutraceuticals Business

WILMINGTON, Del., May 07, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that it has signed a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners LLC (“Turnspire”). The transaction is expected to close in the calendar third quarter 2024, subject to the satisfaction of customary closing conditions.

Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners

Here is how Ashland (ASH) and Buenaventura (BVN) have performed compared to their sector so far this year.

Is Ashland Inc. (ASH) Stock Outpacing Its Basic Materials Peers This Year?

Softer pricing hurts Ashland (ASH) sales for the fiscal second quarter.

Ashland's (ASH) Earnings & Revenues Surpass Estimates in Q2

Ashland beat on earnings but forecasted continued revenue sluggishness. The company sees some key end markets recovering and is lessening its reliance on some more cyclical products.

Why Ashland Stock Fell Today

Ashland Inc. (NYSE:ASH ) Q2 2024 Results Conference Call May 1, 2024 9:00 AM ET Company Participants William Whitaker - Vice President of Finance and Director of Investor Relations Guillermo Novo - Chair and Chief Executive Officer Kevin Willis - Senior Vice President and Chief Financial Officer Conference Call Participants Michael Sison - Wells Fargo Laurence Alexander - Jefferies David Begleiter - Deutsche Bank Chris Parkinson - Wolfe Research Josh Spector - UBS John Roberts - Mizuho Mike Harrison - Seaport Research Partners John McNulty - BMO Operator Good day, and thank you for standing by. Welcome to the Ashland Inc. Second Quarter 2024 Earnings Conference Call.

Ashland Inc. (ASH) Q2 2024 Earnings Call Transcript

The headline numbers for Ashland (ASH) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Ashland (ASH) Reports Q2 Earnings: What Key Metrics Have to Say

Ashland (ASH) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.43 per share a year ago.

Ashland (ASH) Tops Q2 Earnings and Revenue Estimates

WILMINGTON, Del., April 30, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the second quarter of fiscal year 2024, which ended March 31, 2024, and issued its outlook for third quarter and full-year fiscal 2024. The global additives and specialty ingredients company holds leadership positions in high-quality, consumer-focused markets including pharmaceuticals, personal care and architectural coatings.

Ashland reports financial results1 for second quarter fiscal 2024; issues outlook for third quarter and full-year fiscal 2024

WILMINGTON, Del., April 18, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its second-quarter earnings release at approximately 5 p.m. ET on Tuesday, April 30, 2024. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Wednesday, May 1. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com .

Ashland sets date for fiscal 2024 second-quarter earnings release and conference call webcast

Tozier is strategic advisor to the CEO, and former executive vice president and chief financial officer of Albemarle Corporation Tozier is strategic advisor to the CEO, and former executive vice president and chief financial officer of Albemarle Corporation

Ashland Board appoints Scott A. Tozier as new director

WILMINGTON, Del. , April 03, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), the global additives and specialty ingredients company today announced executive organization changes to its personal care and specialty additives businesses.

Ashland announces executive organization changes to personal care and specialty additives

Why Is Ashland (ASH) Up 0.2% Since Last Earnings Report?

Ashland (ASH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

News for Ashland Global Hlds Stock (ASH)